Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01028651 · ClinicalTrials.gov registry record
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension
A clinical trial, sponsored by United Therapeutics.
- Completed
- Registry status
- 13
- Enrollment target
NCT01028651 is a clinical trial that has completed, run by United Therapeutics. The registered enrollment target is 13 participants.
The verdict
NCT01028651 has completed, sponsored by United Therapeutics.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
This was a multicenter, prospective, observational, open-label study. Patients meeting inclusion/exclusion criteria received treatment with treprostinil as recommended by their treating physicians and were followed according to standard of care. This observational study collected clinical data and biologic specimens from patients who were treated for portopulmonary hypertension (PoPH), with a goal of achieving hemodynamic parameters appropriate for orthotopic liver transplantation candidacy, including mean pulmonary arterial pressure (mPAP) less than 35 mmHg and pulmonary vascular resistance (PVR) less than 3 Wood-units (WU) at Week 24 in patients with severe PoPH.
Interventions
- DRUG Treprostinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01028651
The ClinicalTrials.gov registry entry for NCT01028651 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is United Therapeutics, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treprostinil is the first listed.
NCT01028651 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01028651 about?
NCT01028651 is a clinical study titled "A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension". This was a multicenter, prospective, observational, open-label study. Patients meeting inclusion/exclusion criteria received treatment with treprostinil as recommended by their treating physicians and were followed according to standard of care. This observational study collected clinical data and b...
What is the current status of trial NCT01028651?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2011-01. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01028651?
The interventions under investigation include: Treprostinil (DRUG).
Who is sponsoring clinical trial NCT01028651?
This trial is sponsored by United Therapeutics, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.